Currently out of the existing stock ratings of Gobind Singh, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Gobind Singh

Work Performance Price Targets & Ratings Chart

Analyst Gobind Singh works at HC WAINWRIGHT with a stock forecast success ratio of 20% fulfilled within 41.17 days on average.

Gobind Singh’s has documented 33 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on RPHM, Reneo Pharmaceuticals at 08-Sep-2023.

Wall Street Analyst Gobind Singh

Analyst best performing recommendations are on EVLO (EVELO BIOSCIENCES).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%) receiving and performance score of 6.31.

Average potential price target upside

EVLO Evelo Biosciences IMUX Immunic KLDO Kaleido Biosciences PTGX Protagonist Therapeutics PRTA Prothena plc RPHM Reneo Pharmaceuticals

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2

$1.95 (3900.00%)

80

8 months 24 days ago

1/2 (50%)

$-5.88 (-74.62%)

83

Buy

10

$9.96 (24900.00%)

10

1 years 1 months 2 days ago

2/2 (100%)

$4.82 (93.05%)

79

Buy

5

$4.96 (12400.00%)

1 years 1 months 3 days ago

1/1 (100%)

$-0.98 (-16.39%)

4

Buy

280

1 years 2 months 18 days ago

1/3 (33.33%)

$120.6 (75.66%)

6

Buy

50

$49.95 (99900.00%)

12

1 years 5 months 3 days ago

3/4 (75%)

$4.2 (9.17%)

100

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Gobind Singh?

On 2020

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?